Hashemi-Sadraei Neda, Vejpongsa Pimprapa, Baljevic Muhamed, Chen Lei, Idowu Modupe
Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.
Case Rep Hematol. 2015;2015:491567. doi: 10.1155/2015/491567. Epub 2015 Feb 10.
Hemophagocytic lymphohistiocytosis (HLH) is a rare and potential life-threatening clinical syndrome that results from uncontrolled activation of the immune system. Secondary HLH, more commonly observed in adult patients, is seen in the context of underlying triggering conditions. Epstein-Barr virus (EBV) has been recognized as the leading infectious cause and is associated with a poor outcome. As clinical and laboratory features of HLH could overlap with septic shock syndrome in most patients, the diagnosis of HLH, especially in adults, is the most challenging aspect of the disease that results in delayed recognition and treatment of rapidly progressive multiorgan system failure. We report a case of Hemophagocytic lymphohistiocytosis in a patient who presented with signs of septic shock syndrome and we review the literature on the topic.
噬血细胞性淋巴组织细胞增生症(HLH)是一种罕见的、可能危及生命的临床综合征,由免疫系统的失控激活引起。继发性HLH在成年患者中更为常见,见于潜在的触发条件下。爱泼斯坦-巴尔病毒(EBV)已被认为是主要的感染原因,且与不良预后相关。由于大多数患者HLH的临床和实验室特征可能与脓毒性休克综合征重叠,HLH的诊断,尤其是在成人中,是该疾病最具挑战性的方面,会导致对快速进展的多器官系统衰竭的识别和治疗延迟。我们报告一例表现为脓毒性休克综合征体征的噬血细胞性淋巴组织细胞增生症患者,并对该主题的文献进行综述。